Newsletter | January 28, 2026

01.28.26 -- BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

FEATURED ARTICLE

BoB@JPM: Marc Salzberg, M.D., Airway Therapeutics

The Business of Biotech returned to San Francisco for the J.P. Morgan Healthcare Conference. We spoke with Marc Salzberg, M.D., CEO and CMO of Airway Therapeutics, about advancing innovative recombinant surfactant protein D for respiratory and inflammatory diseases, now in Phase 2b/3 trials.

INDUSTRY INSIGHTS

Transforming Drug Development With Statistical Science

Explore how statistical science and computational biology can accelerate drug development. Learn how innovative trial designs and Bayesian statistics can lead to more efficient and successful clinical trials.

At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense

At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.

Survey Says Mobile Nurse Visits Have A Place In Clinical Trials

Discover how mobile visits are transforming clinical trials by reducing barriers to participation, enhancing diversity, and bringing studies closer to patients and their communities.

Managing Drug And Data Requirements In Decentralized Clinical Trials

Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.

Tools For Efficient And Reliable Gene Therapy Manufacturing

Uncover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.

Smarter, Scalable API Manufacturing: Achieving Efficiency With Flow Chemistry

Designed for scientists and engineers evaluating advanced reactors, this recording delivers practical insights and real-world examples to support safer, more efficient, and adaptable flow chemistry.